Mechanistic insights into the metabolomic profiling and anticancer potential of Paspalum dilatatum in breast cancer: integrated phytochemical, in vitro, and in silico studies
Oct 2026· RSC Advances· Vol 16, pp. 66993 - 67005· 0 citations· 54 references
Medicine
TL;DR
The integrated findings position P. dilatatum flavonoids, and acaciin in particular, as computationally prioritized candidates for EGFR-targeted, pro-apoptotic anticancer activity that merit further experimental validation.
Abstract
The study explored the metabolite profile and anticancer potential of Paspalum dilatatum (Dallis grass) using an integrated phytochemical, computational, and in vitro approach. UHPLC/QTOF-MS/MS analysis of a 70% methanolic extract tentatively identified 30 metabolites, mainly flavonoids. In vitro MTT assays showed dose-dependent cytotoxicity against breast cancer MCF7 cells (IC50 = 73.70 µg mL−1) and liver cancer HEPG2 cells (IC50 = 128.02 µg mL−1), with high selectivity over normal Vero cells (p < 0.0001). Mechanistic studies in MCF7 cells demonstrated apoptosis induction, as supported by increased caspase-3 expression (P = 0.0002). Upregulation of the pro-apoptotic protein BAX (P = 0.0013) and downregulation of the anti-apoptotic protein BCL-2 (P = 0.0284) were also demonstrated, with a significant rise in the BAX/BCL-2 ratio (P = 0.0060). Computational docking against EGFR (PDB ID: 8A27) predicted strong binding of acaciin (−9.763 kcal mol−1) and sissotrin (−9.587 kcal mol−1), while molecular dynamics supported the stability of the EGFR–Acaciin complex (RMSD 2.5–3 Å). Overall, the integrated findings position P. dilatatum flavonoids, and acaciin in particular, as computationally prioritized candidates for EGFR-targeted, pro-apoptotic anticancer activity that merit further experimental validation.
Findings indicate that methanolic extract of C. edulis flowers exerts potent anticancer activity predominantly through mitochondrial-mediated apoptosis complemented by a computationally predicted interaction between its major cyclitol constituent and the EGFR kinase domain.
Bader I. Huwaimel, A. Abouzied, Marwa M. Abd Rabo et al.· International Journal of Mol...· 0 citations
Prostate cancer remains one of the leading causes of cancer-related mortality in men, particularly in its castration-resistant form (CRPC), which exhibits resistance to hormonal therapy. The imbalance between proliferation and apoptosis in cancer cells poses a major challenge in developing effective therapeutic strateg...
Eka Yudha Rahman, R. Panghiyangani, Hendra Sutapa et al.· International Journal of Dru...· 0 citations
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer lacking ER, PR, and HER2 expression, often associated with poor prognosis, early relapse, and resistance to conventional chemotherapy. Due to the limited availability of targeted therapies, natural products have gained attention for their st...
S. Sinnarkar, P. Suryawanshi, A. Jadhav et al.· Journal of the Oman Medical...· 0 citations
Cancer is still a major global health challenge, underlining the urgent requirement for safer and more effective treatments. In this present work, the methanolic extract of Cyperus tegetum Roxb., Cyperaceae, was extensively analysed using both biological and computational methods. Many bioactive compounds were found in...
A. Chatterjee, P. K. Das, R. Khanra et al.· Revista Brasileira de Farmac...· 0 citations
Docking experiments suggested strong binding affinities between pheophorbide and EGFR, chlorogenic acid and ERBB2, and chlorogenic acid and MET, supporting their mechanistic relevance in cancer inhibition.
Poonam Joshi, Anjali Tripathi, S. S· Chemistry and Biodiversity· 0 citations